Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKesson
Teva
Chubb
Express Scripts
Baxter

Generated: April 19, 2019

DrugPatentWatch Database Preview

Paragraph IV Challenges

« Back to Dashboard

Drugname Dosage Strength Rld Submissiondate
everolimus Tablets 2.5 mg, 5 mg, and 7.5 mg Afinitor 2014-12-10
lamivudine Tablets 100 mg Epivir-HBV 2007-10-31
metformin hydrochloride Extended-release Tablets 500 mg and 1000 mg Glumetza 2009-07-27
nisoldipine Extended-release Tablets 20 mg and 30 mg Sular 2007-11-07
isotretinoin Capsules 30 mg and 40 mg Absorica 2012-12-31
oxycodone Extended-release Capsules 9 mg, 13.5 mg, 18 mg, 27 mg and 36 mg Xtampza ER208090 2017-11-15
atazanavir sulfate Capsules 100 mg and 150 mg Reyataz 2010-03-19
Drugname Dosage Strength Rld Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
McKesson
Fish and Richardson
Moodys
Julphar
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.